Cerus Corporation has announced a significant leadership transition, appointing Vivek Jayaraman as the new President and Chief Executive Officer, effective July 1, 2026. This change comes as current CEO William 'Obi' Greenman transitions to the role of Executive Chairman of the Board. Jayaraman, who has been with Cerus since March 2020 as Chief Operating Officer, brings a wealth of experience from his previous roles, including Chief Commercial Officer and Vice President of Sales and Marketing at TriVascular Technologies. His appointment is expected to enhance the company's strategic direction and operational execution, particularly as Cerus continues to focus on its innovative blood safety technologies. The company has outlined a comprehensive compensation package for Jayaraman, which includes an annual base salary of $740,000, eligibility for performance-based bonuses, and significant equity awards contingent on company performance. This leadership change is seen as a positive step for Cerus, aligning with its growth strategy and operational goals. The Board of Directors expressed confidence in Jayaraman's ability to lead the company into its next phase of development, emphasizing the importance of strong leadership in navigating the competitive landscape of the medical device industry.

Press Release distribution

National Press Distribution across U.S. Media. Direct Access to Key Decision Making Editors.